S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
S&P 500   4,998.76 (-0.25%)
DOW   37,959.42 (+0.49%)
QQQ   419.58 (-0.90%)
AAPL   165.44 (-0.96%)
MSFT   400.77 (-0.87%)
META   487.66 (-2.82%)
GOOGL   154.77 (-0.79%)
AMZN   176.19 (-1.69%)
TSLA   149.89 (-0.03%)
NVDA   819.22 (-3.25%)
AMD   151.03 (-2.61%)
NIO   3.88 (-3.00%)
BABA   68.75 (-0.19%)
T   16.38 (+0.31%)
F   12.13 (+0.58%)
MU   109.50 (-2.17%)
GE   151.20 (-1.14%)
CGC   7.76 (-0.89%)
DIS   112.11 (-0.28%)
AMC   3.22 (+10.27%)
PFE   25.59 (+0.79%)
PYPL   62.18 (+0.13%)
XOM   120.71 (+1.85%)
Free Trial

Dova Pharmaceuticals (DOVA) News Today

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)
Free DOVA Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Headlines
Stock Analysis
SourceHeadline
uk.finance.yahoo.com logoAnalysis of Co-promotion and Co-marketing Deals in Pharmaceuticals and Biotechnology Signed During 2016-2024
uk.finance.yahoo.com - March 7 at 12:52 PM
bizjournals.com logoFulcrum swings back up after FDA lifts clinical hold
bizjournals.com - August 22 at 5:13 PM
technews.tmcnet.com logoFulcrum Therapeutics Appoints Alex C. Sapir Chief Executive Officer
technews.tmcnet.com - May 15 at 8:47 AM
marketwatch.com logoImmune Thrombocytopenia Market 2023 Size to reach USD 3.33 Billion by 2026 With A 0.54% CAGR
marketwatch.com - March 29 at 10:42 AM
marketwatch.com logoWith A 0.54% CAGR, Immune Thrombocytopenia Market 2023 Size Will Reach USD 3.33 Billion by 2026
marketwatch.com - March 21 at 3:28 PM
marketwatch.com logoLatest Research on Chemotherapy Induced Thrombocytopenia Drugs Market Report 2023-2029
marketwatch.com - February 27 at 5:29 PM
marketwatch.com logoGlobal Immune Thrombocytopenia Treatment Market Size To Grow On The Basis Of Refined Innovation From 2023-2030 By VMReports
marketwatch.com - February 19 at 7:23 AM
finance.yahoo.com logoPasithea Therapeutics Appoints Life Sciences and Health Care Executive Alfred J. Novak to its Board of Directors
finance.yahoo.com - September 20 at 5:34 PM
investing.com logoTethys Oil AB (TETY)
investing.com - September 14 at 8:09 PM
fool.com logoMolina Healthcare (NYSE: MOH)
fool.com - August 11 at 11:25 PM
uk.news.yahoo.com logoUK watchdog fines Pfizer, Flynn Pharma $84 million for overcharging NHS
uk.news.yahoo.com - July 23 at 7:50 AM
marketwatch.com logoGlobal Immune Thrombocytopenia Market to Rise at 0.54% CAGR from 2019-2026
marketwatch.com - July 19 at 7:32 PM
investing.com logoDOVA_old Historical Data
investing.com - June 9 at 6:26 AM
uk.finance.yahoo.com logo'This is not pressure' - Passionate Parker issues rallying cry ahead of huge Blackburn clash
uk.finance.yahoo.com - April 30 at 8:15 PM
reuters.com logoUkraine Holocaust survivors find shelter in Israel
reuters.com - April 30 at 8:15 PM
marketwatch.com logoImmune Thrombocytopenia (ITP) Market Research Update, Size Estimation, Future Scope, Revenue Opportunities and Regional Forecast to 2028
marketwatch.com - March 24 at 11:01 PM
benzinga.com logoVerona Pharma Reports Third Quarter 2021 Financial Results and Provides Corporate Update
benzinga.com - November 9 at 4:14 AM
marketwatch.com logoAdvent, GIC Affiliate Launch $8.1 Bln Takeover Bid for Sweden's Sobi
marketwatch.com - September 2 at 5:38 PM
Get Dova Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter.

Don’t expose yourself to stocks during the week (Ad)

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

DOVA Media Mentions By Week

DOVA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DOVA
News Sentiment
▼
0.00

0.52
▲
Average
Medical
News Sentiment

DOVA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DOVA Articles
This Week
▼
0

0
▲
DOVA Articles
Average Week

Get Dova Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOVA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:DOVA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research